Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndromeCROUCH, Michael A; NAPPI, Jean M; CHEANG, Kai I et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 860-875, issn 1060-0280, 16 p.Article

Inflammation as a therapeutic target: A unique role for abciximabKEREIAKES, Dean J.The American heart journal. 2003, Vol 146, Num 4, pp S1-S4, issn 0002-8703, SUPConference Paper

Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysisCOLLET, J. P; MONTALESCOT, G; LESTY, C et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 1, pp 142-148, issn 1079-5642Article

Potential non-glycoprotein IIb/IIIa effects of abciximabCOLLER, B. S.The American heart journal. 1999, Vol 138, Num 1, pp S1-S5, issn 0002-8703, 2Article

Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjectsHARDER, S; KIRCHMAIER, C. M; KRZYWANEK, H. J et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 11, pp 1175-1181, issn 0009-7322Article

Instant dissolution of intracoronary thrombus by abciximabCHI HANG LEE; KHENG THYE HO; HUAY CHEEM TAN et al.International journal of cardiology. 2005, Vol 104, Num 1, pp 102-103, issn 0167-5273, 2 p.Article

Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregationFRELINGER, Andrew L; FURMAN, Mark I; KRUEGER, Lori A et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 12, pp 1374-1379, issn 0009-7322Article

Abciximab not RGD peptide inhibits von Willebrand factor-dependent platelet activation under shearGOTO, S; ETO, K; IKEDA, Y et al.Lancet (British edition). 1999, Vol 353, Num 9155, issn 0140-6736, p. 809Article

Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies : Discriminating abciximab and small molecular weight antagonistsQUINN, M; DEERING, A; STEWART, M et al.Circulation (New York, N.Y.). 1999, Vol 99, Num 17, pp 2231-2238, issn 0009-7322Article

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACSLENDERINK, Timo; BOERSMA, Eric; RUZYLLO, Witold et al.The American heart journal. 2004, Vol 147, Num 5, pp 865-873, issn 0002-8703, 9 p.Article

Thrombocytopenia associated with c7E3 Fab (abciximab)SCHELL, D. A; GANTI, A. K; LEVITT, R et al.Annals of hematology (Print). 2002, Vol 81, Num 2, pp 76-79, issn 0939-5555Article

Paradoxical inhibition of fibrinogen binding and potentiation of α-granule release by specific types of inhibitors of glycoprotein IIb-IIIaSCHNEIDER, D. J; TAATJES, D. J; SOBEL, B. E et al.Cardiovascular research. 2000, Vol 45, Num 2, pp 437-446, issn 0008-6363Article

A quick simple method of determining platelet aggregability following glycoprotein IIb/IIIa receptor inhibitor administrationPOULLIS, M.Cardiology. 1999, Vol 91, Num 3, pp 156-160, issn 0008-6312Article

Different activation states of GP IIb/IIIa complexes in plateletsNURDEN, A. T; POUJOL, C; NURDEN, P et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S67-S70, issn 0957-5235, SUP1Conference Paper

Platelet glycoprotein IIb/IIIa inhibitors : Basic and clinical aspectsNURDEN, A. T; POUJOL, C; DURRIEU-JAIS, C et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 12, pp 2835-2840, issn 1079-5642Article

Abciximab in patients with ruptured intracranial aneurysmsAVIV, Richard I; O'NEILL, Richard; PATEL, Maneesh C et al.American journal of neuroradiology. 2005, Vol 26, Num 7, pp 1744-1750, issn 0195-6108, 7 p.Article

Effect of Ca²⁺ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofibanMARCINIAK, Stanley J; JORDAN, Robert E; MASCELLI, Mary A et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 539-543, issn 0340-6245Article

In vitro dose response to different GPIIb/IIIa-antagonists : Inter-laboratory comparison of various platelet function testsHARDER, S; KLINKHARDT, U; BREDDIN, H. K et al.Thrombosis research. 2001, Vol 102, Num 1, pp 39-48, issn 0049-3848Article

Myocardrevaskularisation nach Vorbehandlung mit dem GPIIb/IIIa-Rezeptorblocker Abciximab = Myocardial revascularization after pretreatment with the GPIIb/IIIa-receptor antagonist abciximabVAHL, C.-F; KAYHAN, N; THOMAS, G et al.Zeitschrift für Kardiologie (Print). 2001, Vol 90, Num 12, pp 889-897, issn 0300-5860Article

In vivo demonstration of an antithrombin effect of AbciximabAMBROSE, J. A; HAWKEY, M; DOSS, R et al.The American journal of cardiology. 2000, Vol 86, Num 2, pp 150-152, issn 0002-9149Article

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockadeMASCELLI, M. A; LANCE, E. T; DAMARAJU, L et al.Circulation (New York, N.Y.). 1998, Vol 97, Num 17, pp 1680-1688, issn 0009-7322Article

Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapyHOLMES, Michael B; SCHNEIDER, David J; HAYES, Michael G et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 17, pp 2051-2057, issn 0009-7322Article

Abciximab for thrombolysis during intracranial aneurysm coilingGRALLA, Jan; RENNIE, Adam T. M; CORKILL, Rufus A et al.Neuroradiology (Berlin. Print). 2008, Vol 50, Num 12, pp 1041-1047, issn 0028-3940, 7 p.Article

Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitorsASTER, Richard H; CURTIS, Brian R; BOUGIE, Daniel W et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 5, pp 569-577, issn 0094-6176, 9 p.Article

Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expressionSTEINER, Sabine; SEIDINGER, Daniela; HUBER, Kurt et al.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 9, pp 1697-1702, issn 1079-5642, 6 p.Article